Oral antivirals for chronic hepatitis B.

@article{Min2007OralAF,
  title={Oral antivirals for chronic hepatitis B.},
  author={Albert D. Min and Jules L. Dienstag},
  journal={Clinics in liver disease},
  year={2007},
  volume={11 4},
  pages={851-68, ix}
}
Four oral antiviral agents have been approved by the United States Food and Drug Administration (FDA) for the treatment of chronic hepatitis B: lamivudine, adefovir, entecavir, and telbivudine. This article reviews the durability of response, dose regimen, predictors of response, safety, and problems with resistance of these four agents and of promising agents currently in phase III clinical trials for the treatment of patients who have hepatitis B e antigen-positive and -negative chronic… CONTINUE READING
11 Extracted Citations
67 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 11 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 67 references

Two-year results from the GLOBE trial in patients with hepatitis B: greater clinical and antiviral efficacy for telbivudine (LdT) vs. lamivudine

  • CL Lai, E Gane, C-W Hsu
  • Hepatology
  • 2006
Highly Influential
6 Excerpts

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B

  • TT Chang, RG Gish, R de Man
  • N Engl J Med
  • 2006
Highly Influential
4 Excerpts

Long-term adefovir dipivoxil treatment induces regression of liver fibrosis in patients with HBeAg-negative chronic hepatitis B: results after 5 years of therapy [abstract]. Hepatology 2005;42:754A

  • SJ Hadziyannis, NC Tassopoulos, TT Chang
  • 2005
Highly Influential
3 Excerpts

Adding - on versus switchingto adefovir therapy in lamivudineresistant HBeAgnegative chronic hepatitis B

  • I Rapti, E Dimou, P Mitsoula
  • Hepatology
  • 2007

Four year assessment of ETV resistance in nucleoside-naı̈ve and lamivudine refractory patients. Presented at the 42nd Annual Meeting of the European Association for the Study of the Liver

  • R Colonno, RE Rose, K Pokornowski
  • 2007
1 Excerpt

Four year assessment of ETV resistance in nucleosidenaı̈ve and lamivudine refractory patients

  • R Colonno, RE Rose, K Pokornowski
  • Presented at the 42 nd Annual Meeting of the…
  • 2007

Telbivudine GLOBE trial at year two : efficacy , safety , and predictors of outcome in patients with chronic hepatitis B [ abstract ]

  • S Han, C Lai, EJ Gane
  • Gastroenterology
  • 2007

Telbivudine GLOBE trial at year two: efficacy, safety, and predictors of outcome in patients with chronic hepatitis

  • S Han, C Lai, EJ Gane
  • B [abstract]. Gastroenterology
  • 2007
1 Excerpt

Similar Papers

Loading similar papers…